Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Lymphoma

  Free Subscription

Articles published in Oncogene

Retrieve available abstracts of 30 articles:
HTML format

Single Articles

    May 2021
  1. KUNOU S, Shimada K, Takai M, Sakamoto A, et al
    Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.
    Oncogene. 2021 May 16. pii: 10.1038/s41388-021-01829.
    PubMed     Abstract available

    November 2020
  2. WANG X, Song Y, Chen W, Ding N, et al
    Germline variants of DNA repair genes in early onset mantle cell lymphoma.
    Oncogene. 2020 Nov 15. pii: 10.1038/s41388-020-01542.
    PubMed     Abstract available

  3. AHUJA A, Journo G, Eitan R, Rubin E, et al
    High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01549.
    PubMed     Abstract available

    October 2020
  4. ABD-ELRAHMAN I, Nassar T, Khairi N, Perlman R, et al
    Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma.
    Oncogene. 2020 Oct 30. pii: 10.1038/s41388-020-01529.
    PubMed     Abstract available

  5. YOSHIDA A, Choi J, Jin HR, Li Y, et al
    Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01532.
    PubMed     Abstract available

    August 2020
  6. TOTANI H, Shinjo K, Suzuki M, Katsushima K, et al
    Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma.
    Oncogene. 2020 Aug 4. pii: 10.1038/s41388-020-01393.
    PubMed     Abstract available

    June 2020
  7. ANDERSON KJ, Osvaldsdottir AB, Atzinger B, Traustadottir GA, et al
    The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma.
    Oncogene. 2020 Jun 12. pii: 10.1038/s41388-020-1347.
    PubMed     Abstract available

  8. RICHART L, Felipe I, Delgado P, Andres MP, et al
    Bptf determines oncogenic addiction in aggressive B-cell lymphomas.
    Oncogene. 2020;39:4884-4895.
    PubMed     Abstract available

    February 2020
  9. LAZARIAN G, Friedrich C, Quinquenel A, Tran J, et al
    Stabilization of beta-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma.
    Oncogene. 2020 Feb 7. pii: 10.1038/s41388-020-1183.
    PubMed     Abstract available

    December 2019
  10. RAJAN SS, Amin AD, Li L, Rolland DC, et al
    The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma.
    Oncogene. 2019 Dec 5. pii: 10.1038/s41388-019-1136.
    PubMed     Abstract available

    November 2019
  11. DENGLER MA, Teh CE, Thijssen R, Gangoda L, et al
    Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma.
    Oncogene. 2019 Nov 26. pii: 10.1038/s41388-019-1122.
    PubMed     Abstract available

  12. SHOUMARIYEH K, Schneider N, Poggio T, Veratti P, et al
    A novel conditional NPM-ALK-driven model of CD30+ T-cell lymphoma mediated by a translational stop cassette.
    Oncogene. 2019 Nov 21. pii: 10.1038/s41388-019-1058.
    PubMed     Abstract available

    October 2019
  13. NJERU SN, Kraus J, Meena JK, Lechel A, et al
    Aneuploidy-inducing gene knockdowns overlap with cancer mutations and identify Orp3 as a B-cell lymphoma suppressor.
    Oncogene. 2019 Oct 28. pii: 10.1038/s41388-019-1073.
    PubMed     Abstract available

    May 2019
  14. NAKAYAMA R, Ueno Y, Ueda K, Honda T, et al
    Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
    Oncogene. 2019;38:4340-4351.
    PubMed     Abstract available

    February 2019
  15. VAZQUEZ-DOMINGUEZ I, Gonzalez-Sanchez L, Lopez-Nieva P, Fernandez-Navarro P, et al
    Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0746.
    PubMed     Abstract available

    October 2018
  16. GUO H, Zeng D, Zhang H, Bell T, et al
    Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma.
    Oncogene. 2018 Oct 25. pii: 10.1038/s41388-018-0550.
    PubMed     Abstract available

    July 2018
  17. ALQARNI S, Al-Sheikh Y, Campbell D, Drotar M, et al
    Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.
    Oncogene. 2018;37:3998-4012.
    PubMed     Abstract available

    April 2018
  18. HU T, Chong Y, Qin H, Kitamura E, et al
    The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.
    Oncogene. 2018;37:1926-1938.
    PubMed     Abstract available

    March 2018
  19. DING L, Zhang Y, Han L, Fu L, et al
    Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis.
    Oncogene. 2018;37:1293-1307.
    PubMed     Abstract available

    February 2018
  20. DEBERNARDI J, Hollville E, Lipinski M, Wiels J, et al
    Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt's lymphoma cells.
    Oncogene. 2018 Feb 14. pii: 10.1038/s41388-018-0123.
    PubMed     Abstract available

    January 2018
  21. ESTEVE-ARENYS A, Valero JG, Chamorro-Jorganes A, Gonzalez D, et al
    The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0111.
    PubMed     Abstract available

    August 2017
  22. MOYO TK, Wilson CS, Moore DJ, Eischen CM, et al
    Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.
    Oncogene. 2017;36:4653-4661.
    PubMed     Abstract available

    July 2017
  23. GUO X, Koff JL, Moffitt AB, Cinar M, et al
    Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
    Oncogene. 2017;36:4224-4232.
    PubMed     Abstract available

  24. WU TS, Tan CT, Chang CC, Lin BR, et al
    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    May 2017
  25. TONELLI C, Morelli MJ, Sabo A, Verrecchia A, et al
    Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas.
    Oncogene. 2017;36:2921-2929.
    PubMed     Abstract available

  26. GOTO H, Kariya R, Kudo E, Okuno Y, et al
    Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Abstract available

  27. PUCCETTI MV, Fischer MA, Arrate MP, Boyd KL, et al
    Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution.
    Oncogene. 2017;36:2553-2564.
    PubMed     Abstract available

  28. DAI L, Lin Z, Qiao J, Chen Y, et al
    Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Abstract available

    April 2017
  29. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Abstract available

    February 2017
  30. SAUER M, Schuldner M, Hoffmann N, Cetintas A, et al
    CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells.
    Oncogene. 2017;36:933-941.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.